Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application

被引:60
作者
Menard, Cedric [1 ,2 ,3 ]
Tarte, Karin [1 ,2 ,3 ]
机构
[1] CHU Rennes, Etab Francais du Sang Bretagne, SITI Lab, F-35043 Rennes, France
[2] INSERM, Fac Med, U917, F-35043 Rennes, France
[3] Univ Rennes 1, UMR 917, F-35043 Rennes, France
来源
STEM CELL RESEARCH & THERAPY | 2013年 / 4卷
关键词
VERSUS-HOST-DISEASE; STEM-CELLS; BONE-MARROW; INDOLEAMINE 2,3-DIOXYGENASE; STEROID-RESISTANT; ADIPOSE-TISSUE; T-CELLS; METHYLATION; RECRUITMENT; EXPRESSION;
D O I
10.1186/scrt214
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Mesenchymal stromal cell (MSC)-based therapy holds great promise for treating immune disorders and for regenerative medicine in agreement with their paracrine trophic and immunosuppressive activities. Various processes have been developed worldwide to produce clinical grade MSCs but, so far, it is not known if one given MSC is more efficient than another. In addition, while their broad activity on innate and adaptative immune cell subsets is now widely admitted, the precise mechanisms supporting their immunoregulatory capacities are still a matter of debate. Finally, quantitative immunological potency assays correlated to clinical efficacy and clinically relevant immunomonitoring approaches for MSC-treated patients are sorely needed. Multiple parameters could influence the immunomodulatory potential of therapeutic MSCs. The most important challenge is now to differentiate, within a high number of poorly comparable and even contradictory pre-clinical studies, the parameters that could have some clinical impact from those that are only due to uncontrolled experimental variability. Importantly, besides MSC-related differences, primarily linked to production processes, several important variables associated with immune assays themselves, including selection of effector immune cells, activation signals, and read-out techniques, should be carefully considered to obtain solid results with potential therapeutic application. In this review, we establish a core of common and reproducible immunological properties of MSCs, shed light on technical issues concerning immunomodulatory potential assessment, and put them into perspective when considering clinical application.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Mechanisms of Immune Modulation by Mesenchymal Stromal Cells and Clinical Translation
    Stagg, J.
    Galipeau, J.
    CURRENT MOLECULAR MEDICINE, 2013, 13 (05) : 856 - 867
  • [32] Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress
    Wu, Xiaomo
    Jiang, Ju
    Gu, Zhongkai
    Zhang, Jinyan
    Chen, Yang
    Liu, Xiaolong
    STEM CELL RESEARCH & THERAPY, 2020, 11 (01)
  • [33] MULTIPOTENT MESENCHYMAL STROMAL CELLS: Clinical Applications and Cancer Modeling
    Rodriguez, Rene
    Garcia-Castro, Javier
    Trigueros, Cesar
    Garcia Arranz, Mariano
    Menendez, Pablo
    STEM CELL TRANSPLANTATION, 2012, 741 : 187 - 205
  • [34] Canine Corneal Stromal Cells Have Multipotent Mesenchymal Stromal Cell Properties In Vitro
    Kafarnik, Christiane
    McClellan, Alyce
    Dziasko, Marc
    Daniels, Julie T.
    Guest, Deborah J.
    STEM CELLS AND DEVELOPMENT, 2020, 29 (07) : 425 - 439
  • [35] Manufacturing mesenchymal stromal cells for phase I clinical trials
    Hanley, Patrick J.
    Mei, Zhuyong
    Cabreira-Hansen, Maria da Graca
    Klis, Mariola
    Li, Wei
    Zhao, Yali
    Durett, April G.
    Zheng, Xingwu
    Wang, Yongping
    Gee, Adrian P.
    Horwitz, Edwin M.
    CYTOTHERAPY, 2013, 15 (04) : 416 - 422
  • [36] Mesenchymal stromal cells with enhanced therapeutic properties
    Girdlestone, John
    IMMUNOTHERAPY, 2016, 8 (12) : 1405 - 1416
  • [37] Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugs
    Girdlestone, John
    Pido-Lopez, Jeffrey
    Srivastava, Saket
    Chai, Jianguo
    Leaver, Neil
    Galleu, Antonio
    Lombardi, Giovanna
    Navarrete, Cristina V.
    CYTOTHERAPY, 2015, 17 (09) : 1188 - 1199
  • [38] Impact of platelet lysate on immunoregulatory characteristics of equine mesenchymal stromal cells
    Moellerberndt, Julia
    Niebert, Sabine
    Fey, Kerstin
    Hagen, Alina
    Burk, Janina
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [39] Towards the standardization of methods of tissue processing for the isolation of mesenchymal stromal cells for clinical use
    Garcia-Munoz, Elisabeth
    Vives, Joaquim
    CYTOTECHNOLOGY, 2021, 73 (03) : 513 - 522
  • [40] Mesenchymal stromal cells for corneal transplantation: Literature review and suggestions for successful clinical trials
    Oh, Joo Youn
    Kim, Eunjae
    Yun, Young In
    Lee, Ryang Hwa
    OCULAR SURFACE, 2021, 20 : 185 - 194